RxDoctor Payments Data

Christopher Dixon

Urology · New York, NYNPI 1134113673

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $78,119 of the $115,924 with a category attached, or 67.4%. Boston Scientific accounts for 93.6% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $36,420 and has fallen 86.7% since, to $4,856 in 2025. Among urology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$115,924in general payments, 2019–2025

Across 153 payments — averaging $757.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$109K
  • Koelis Inc.$6K
  • Astellas Pharma US Inc$267
  • SRS Medical Systems, Inc.$138
  • Ferring Pharmaceuticals Inc.$101
  • Bayer$88
  • plus $400 from 10 others

What the payments were for

  • Consulting fees$5,2505%
  • Speaking & faculty fees$78,11967%
  • Travel & lodging$29,08425%
  • Food & beverage$3,4713%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$115,924 in reported general payments places this provider in the 95th percentile of 952 urology providers in New York.

See all urology providers in New York →

Other urology in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →